AMT Prepares for Submission of Marketing Authorization Dossier for AMT-011 (G... (to the prospectus of AMT's initial publi...)

(Date:12/17/2009)... Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS ) today ... at four weeks for the first dose cohort, 200 mg ... combination with pegylated interferon and ribavirin (SOC) in HCV patients. ... levels of virus (<15 IU/ml) at week 4, known as ... RVR, compared to 20% of patients receiving placebo plus SOC. ...

(Date:12/17/2009)... 17 The Make-A-Wish Foundation announced today ... from the LATISSE ® ... Allergan, Inc. ,, Based on the tradition of ... come true, the campaign launched earlier this year ... Foundation by leveraging the excitement around the availability ...

(Date:12/16/2009)... According to Millennium Research Group (MRG), ... although the US minimally invasive spinal fusion market ... of over 12% through 2014, reimbursement concerns in ... market, which previously had been forecast at almost ... Invasive Spine Technologies 2010 report ...

Breaking Medicine Technology:ANA598 Demonstrates Positive 4-Week Results at 200 mg BID 2 ANA598 Demonstrates Positive 4-Week Results at 200 mg BID 3 ANA598 Demonstrates Positive 4-Week Results at 200 mg BID 4 ANA598 Demonstrates Positive 4-Week Results at 200 mg BID 5 ANA598 Demonstrates Positive 4-Week Results at 200 mg BID 6 ANA598 Demonstrates Positive 4-Week Results at 200 mg BID 7 The Make-A-Wish Foundation(R) Receives $1 Million Donation from LATISSE(R) Wishes Campaign 2 The Make-A-Wish Foundation(R) Receives $1 Million Donation from LATISSE(R) Wishes Campaign 3 The Make-A-Wish Foundation(R) Receives $1 Million Donation from LATISSE(R) Wishes Campaign 4 The Make-A-Wish Foundation(R) Receives $1 Million Donation from LATISSE(R) Wishes Campaign 5 Reimbursement Difficulties With TranS1's AxiaLIF and NuVasive's XLIF Have Sceptics Talking 2 Reimbursement Difficulties With TranS1's AxiaLIF and NuVasive's XLIF Have Sceptics Talking 3 American Laser Centers Names Health Care Veteran Steven Straus CEO 59137 1 American Laser Centers Names Health Care Veteran Steven Straus CEO 59137 2 Grocery Produce Fighting for a Cause Wholly Pink Guacamole 14395 1 Grocery Produce Fighting for a Cause Wholly Pink Guacamole 14395 2 Noninvasive Medical Technologies Awarded ISO 13485 Quality Certification 5331 1 Noninvasive Medical Technologies Awarded ISO 13485 Quality Certification 5331 2

[0] ANA598 Demonstrates Positive 4-Week Results at 200 mg BID [0] The Make-A-Wish Foundation(R) Receives $1 Million Donation from LATISSE(R) Wishes Campaign [0] Reimbursement Difficulties With TranS1's AxiaLIF and NuVasive's XLIF Have Sceptics Talking

... Additional Data Demonstrated Higher Overall Maintenance of Healed ... Symptom Relief versus Placebo --, SAN DIEGO, May ... three pivotal Phase 3 studies evaluating,investigational new drug TAK-390MR, ... delayed release technology, in healing patients,with erosive esophagitis (EE) ...

... MONTVALE, N.J., May 16 Memory Pharmaceuticals,Corp. (Nasdaq: ... key development,programs at its R&D Day meeting with ... for MEM 1414, its lead PDE4 inhibitor,demonstrating the ... has nominated MEM 68626 as the lead development ...

Other Medicine Technology:TAP Pharmaceutical Products Inc. Announces Phase 3 TAK-390MR Data Demonstrating Higher Overall Healing Versus Lansoprazole in Patients with Erosive Esophagitis 2 TAP Pharmaceutical Products Inc. Announces Phase 3 TAK-390MR Data Demonstrating Higher Overall Healing Versus Lansoprazole in Patients with Erosive Esophagitis 3 TAP Pharmaceutical Products Inc. Announces Phase 3 TAK-390MR Data Demonstrating Higher Overall Healing Versus Lansoprazole in Patients with Erosive Esophagitis 4 Memory Pharmaceuticals Highlights Progress with Key Programs at its R&D Day 2 Memory Pharmaceuticals Highlights Progress with Key Programs at its R&D Day 3 Memory Pharmaceuticals Highlights Progress with Key Programs at its R&D Day 4

TAP Pharmaceutical Products Inc. Announces Phase 3 TAK-390MR Data Demonstrating Higher Overall Healing Versus Lansoprazole in Patients with Erosive Esophagitis Memory Pharmaceuticals Highlights Progress with Key Programs at its R&D Day

(Date:12/17/2009)... New protocol for neck and low back pain is now available ... for disc and nerve problems. Patients sometimes even fall asleep ... ... -- Back pain sufferers from all over Maryland can now rejoice ... protocol to help save and improve degenerated discs., , ,Humans are ...

(Date:12/17/2009)... Morbidity and Mortality Weekly Report (MMWR) released a ... has decreased steadily since 2004, with a marked ... also a substantial decrease in core epidemiology capacity ... bioterrorism and emergency response. For some ... abuse, and oral health, basic epidemiology capacity in ...

(Date:12/17/2009)... The National Council on Disability ... JW Marriott Houston, 5150 Westheimer, Houston, TX, beginning at ... at 11:00 a.m. on Thursday, January 21, 2010. This ... believes it is vital to hear from communities around ... for people with disabilities. This meeting will provide another ...

(Date:12/17/2009)... disparities in cancer survival are greatest for cancers ... including breast and prostate cancer, according to a ... of Public Health and Herbert Irving Comprehensive Cancer ... Disparities are small or nonexistent for cancers ... options, such as pancreatic and lung cancer. ...

(Date:12/17/2009)... Surgery Arts of New Jersey (PSANJ) is pleased to announce its ... cosmetic surgery center in the New York Tri-State Area often featured ... , ... New Brunswick, NJ (PRWEB) December 17, 2009 ... announce its newly redesigned Web site: www.psanj.com . PSANJ is ...

Breaking Medicine News(10 mins):Health News:Rockville and Gaithersburg Now Has Spinal Decompression Therapy 2 Health News:Rockville and Gaithersburg Now Has Spinal Decompression Therapy 3 Health News:CSTE National Assessment Finds Critical Public Health Disease Surveillance Capacity Lacking 2 Health News:National Council on Disability to Hold Houston Meeting to Hear Issues Affecting People With Disabilities 2 Health News:Cancer survival disparities for most minority populations increase as cancers become more treatable 2 Health News:Plastic Surgery Arts of New Jersey (PSANJ) Launches New Web Site 2 Health News:Plastic Surgery Arts of New Jersey (PSANJ) Launches New Web Site 3

[0] Rockville and Gaithersburg Now Has Spinal Decompression Therapy [0] CSTE National Assessment Finds Critical Public Health Disease Surveillance Capacity Lacking [0] National Council on Disability to Hold Houston Meeting to Hear Issues Affecting People With Disabilities [0] Cancer survival disparities for most minority populations increase as cancers become more treatable [0] Plastic Surgery Arts of New Jersey (PSANJ) Launches New Web Site

... Growth ... ... 8 Barr,Pharmaceuticals, Inc. (NYSE: BRL ) today reported net earnings ... 2007,compared to net earnings of $52.8 million, or $0.49 per share, for ...

... -- Reaffirms Earnings Projections for 2007 --, LAKE FOREST, Ill., ... hospital products company, today reported,results for the third quarter ended Sept. ... million in the third quarter of 2007, ... Net sales excluding Mayne Pharma sales grew 4.0 ...

... The following was written,by Frankie L. Trull, President of ... research are seeking to stimulate a debate where,none exists, ... Some people believe in the power and promise ... Others oppose animal research,and its inherent power and promise. ...

... The Angler,s Aid Rod,Holder has a suspender-like harness ... one hand. The Eliminator Racing Chair is recommended ... easy transfer in and out,of the chair. ... who brave the elements or crave competition, Good ...

... ROANOKE, Va., Nov. 8 This should be a ... to the next can wear on the body,and dampen the ... can provide you with the comfort, support, and,protection your body ... each other and that requires,some travel for them to be ...

... Fong will lead sales and marketing of CTI products, ... and MTAX: CTIC) announced today that Jim Fong has ... CTI with,more than 20 years of sales and marketing ... Therapeutics (CVT) in Palo Alto,California, where he led the ...

Barr Reports Third Quarter 2007 GAAP Earnings of $0.36 Per Share; Adjusted Earnings of $0.75 Per Share Hospira Reports Third-Quarter 2007 Results Go Ahead, Prove the Negative Holiday Gift Giving for Outdoor Enthusiasts With Disabilities and Special Needs Holiday Travel Causing Stress?Cell Therapeutics, Inc. (CTI) Appoints Jim Fong as Vice President, Commercial Operations

... The rHead Radial Implant System ... anatomic solution to radial head replacement. ... address varied patient anatomy while minimizing ... A uniquely designed alignment guide assists ...

For use in implant arthroplasty associated with comminuted fractures, or rheumatoid, degenerative or post-traumatic disease of the radial head. Designed for higher demand patients requiring superior ...

For connection to the bipolar output of electrosurgical generators....

This legless table has adjustable height and blade post. Includes standard 2" (5 cm) pad....

Medicine Products:

rHead Radial Implant System Swanson Titanium Radial Head Implants Jeweler Forceps, Insulated and Uninsulated Carpa™ Table

AMT Prepares for Submission of Marketing Authorization Dossier for AMT-011 (G...(to the prospectus of AMT's initial publi...),Health